NANOVIRICIDES, INC. Basic Shares Outstanding (Weighted Average)
NANOVIRICIDES, INC. (NNVC) reported Basic Shares Outstanding (Weighted Average) of 21.61 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-15
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 21.61M shares, a 34.84% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 19.85M shares, a 36.22% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 17.08M shares, a 24.54% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 16.18M shares, a 32.19% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 15.12M shares, a 27.34% increase from fiscal 2024.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 11.87M shares, a 2.11% increase from fiscal 2023.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 11.63M shares, a 0.79% increase from fiscal 2022.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 11.53M shares, a 5.81% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | 21.61M shares 10-Q · filed 2026-05-15 | 20.73M shares derived: average of 2 quarters · filed 2026-05-15 | 19.50M shares 10-Q · filed 2026-05-15 | 18.68M shares derived: average of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | 19.85M shares 10-Q · filed 2026-02-17 | 18.47M shares 10-Q · filed 2026-02-17 | 17.70M shares derived: average of 3 quarters · filed 2026-02-17 | 17.28M shares derived: average of 4 quarters · filed 2026-05-15 | |
| 2025-09-30 | 17.08M shares 10-Q · filed 2025-11-14 | 16.63M shares derived: average of 2 quarters · filed 2025-11-14 | 16.43M shares derived: average of 3 quarters · filed 2026-05-15 | 15.97M shares derived: average of 4 quarters · filed 2026-05-15 | |
| 2025-06-30 | 16.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 16.10M shares derived: average of 2 quarters · filed 2026-05-15 | 15.59M shares derived: average of 3 quarters · filed 2026-05-15 | 15.12M shares 10-K · filed 2025-09-29 | |
| 2025-03-31 | 16.03M shares 10-Q · filed 2026-05-15 | 15.30M shares derived: average of 2 quarters · filed 2026-05-15 | 14.76M shares 10-Q · filed 2026-05-15 | 14.14M shares derived: average of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | 14.57M shares 10-Q · filed 2026-02-17 | 14.13M shares 10-Q · filed 2026-02-17 | 13.51M shares derived: average of 3 quarters · filed 2026-02-17 | 13.08M shares derived: average of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | 13.72M shares 10-Q · filed 2025-11-14 | 12.98M shares derived: average of 2 quarters · filed 2025-11-14 | 12.58M shares derived: average of 3 quarters · filed 2025-11-14 | 12.37M shares derived: average of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | 12.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 12.01M shares derived: average of 2 quarters · filed 2025-09-29 | 11.92M shares derived: average of 3 quarters · filed 2025-09-29 | 11.87M shares 10-K · filed 2025-09-29 | |
| 2024-03-31 | 11.78M shares 10-Q · filed 2025-05-15 | 11.76M shares derived: average of 2 quarters · filed 2025-05-15 | 11.75M shares 10-Q · filed 2025-05-15 | 11.73M shares derived: average of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | 11.75M shares 10-Q · filed 2025-02-14 | 11.73M shares 10-Q · filed 2025-02-14 | 11.71M shares derived: average of 3 quarters · filed 2025-02-14 | 11.69M shares derived: average of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | 11.72M shares 10-Q · filed 2024-11-14 | 11.69M shares derived: average of 2 quarters · filed 2024-11-14 | 11.67M shares derived: average of 3 quarters · filed 2024-11-14 | 11.66M shares derived: average of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | 11.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | 11.65M shares derived: average of 2 quarters · filed 2024-09-27 | 11.64M shares derived: average of 3 quarters · filed 2024-09-27 | 11.63M shares 10-K · filed 2024-09-27 | |
| 2023-03-31 | 11.64M shares 10-Q · filed 2024-05-15 | 11.62M shares derived: average of 2 quarters · filed 2024-05-15 | 11.61M shares 10-Q · filed 2024-05-15 | 11.60M shares derived: average of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | 11.61M shares 10-Q · filed 2024-02-14 | 11.60M shares 10-Q · filed 2024-02-14 | 11.59M shares derived: average of 3 quarters · filed 2024-02-14 | 11.58M shares derived: average of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | 11.59M shares 10-Q · filed 2023-11-14 | 11.57M shares derived: average of 2 quarters · filed 2023-11-14 | 11.56M shares derived: average of 3 quarters · filed 2023-11-14 | 11.55M shares derived: average of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 11.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | 11.55M shares derived: average of 2 quarters · filed 2023-10-13 | 11.54M shares derived: average of 3 quarters · filed 2023-10-13 | 11.53M shares 10-K · filed 2023-10-13 | |
| 2022-03-31 | 11.54M shares 10-Q · filed 2023-05-15 | 11.54M shares 10-Q · filed 2022-05-16 | 11.53M shares derived: average of 2 quarters · filed 2023-05-15 | 11.53M shares 10-Q · filed 2023-05-15 | 11.52M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 11.53M shares 10-Q · filed 2023-02-14 | 11.52M shares 10-Q · filed 2023-02-14 | 11.51M shares derived: average of 3 quarters · filed 2023-02-14 | 11.37M shares derived: average of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | 11.52M shares 10-Q · filed 2022-11-14 | 11.51M shares derived: average of 2 quarters · filed 2022-11-14 | 11.32M shares derived: average of 3 quarters · filed 2022-11-14 | 11.16M shares derived: average of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | 11.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-13 | 11.23M shares derived: average of 2 quarters · filed 2022-10-13 | 11.04M shares derived: average of 3 quarters · filed 2022-10-13 | 10.90M shares 10-K · filed 2022-10-13 | |
| 2021-03-31 | 10.95M shares 10-Q · filed 2022-05-16 | 10.81M shares derived: average of 2 quarters · filed 2022-05-16 | 10.70M shares 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | 10.67M shares 10-Q · filed 2022-02-14 | 10.58M shares 10-Q · filed 2022-02-14 | |||
| 2020-09-30 | 10.49M shares 10-Q · filed 2021-11-15 | ||||
| 2018-06-30 | 68.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | 66.53M shares derived: average of 2 quarters · filed 2018-10-12 | 65.46M shares derived: average of 3 quarters · filed 2018-10-12 | 64.92M shares 10-K · filed 2018-10-12 | |
| 2018-03-31 | 64.07M shares 10-Q · filed 2018-05-21 | 63.70M shares derived: average of 2 quarters · filed 2018-05-21 | 63.57M shares 10-Q · filed 2018-05-21 | 63.44M shares derived: average of 4 quarters · filed 2018-10-12 | |
| 2017-12-31 | 63.34M shares 10-Q · filed 2018-02-20 | 63.32M shares 10-Q · filed 2018-02-20 | 63.24M shares derived: average of 3 quarters · filed 2018-10-12 | 62.68M shares derived: average of 4 quarters · filed 2018-10-12 | |
| 2017-09-30 | 63.31M shares 10-Q · filed 2017-11-14 | 63.19M shares derived: average of 2 quarters · filed 2018-10-12 | 62.46M shares derived: average of 3 quarters · filed 2018-10-12 | 61.39M shares derived: average of 4 quarters · filed 2018-10-12 | |
| 2017-06-30 | 63.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | 62.03M shares derived: average of 2 quarters · filed 2018-10-12 | 60.76M shares derived: average of 3 quarters · filed 2018-10-12 | 60.10M shares 10-K · filed 2018-10-12 | |
| 2017-03-31 | 61.00M shares 10-Q · filed 2018-05-21 | 59.60M shares derived: average of 2 quarters · filed 2018-05-21 | 59.12M shares 10-Q · filed 2018-05-21 | 58.84M shares derived: average of 4 quarters · filed 2018-10-12 | |
| 2016-12-31 | 58.21M shares 10-Q · filed 2018-02-20 | 58.19M shares 10-Q · filed 2018-02-20 | 58.12M shares derived: average of 3 quarters · filed 2018-10-12 | 58.05M shares derived: average of 4 quarters · filed 2018-10-12 | |
| 2016-09-30 | 58.18M shares 10-Q · filed 2017-11-14 | 58.08M shares derived: average of 2 quarters · filed 2018-10-12 | 58.00M shares derived: average of 3 quarters · filed 2018-10-12 | 57.90M shares derived: average of 4 quarters · filed 2018-10-12 | |
| 2016-06-30 | 57.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-12 | 57.91M shares derived: average of 2 quarters · filed 2018-10-12 | 57.80M shares derived: average of 3 quarters · filed 2018-10-12 | 57.67M shares 10-K · filed 2018-10-12 | |
| 2016-03-31 | 57.84M shares 10-Q · filed 2017-05-15 | 57.71M shares derived: average of 2 quarters · filed 2017-05-15 | 57.57M shares 10-Q · filed 2017-05-15 | 57.46M shares derived: average of 4 quarters · filed 2017-09-28 | |
| 2015-12-31 | 57.59M shares 10-Q · filed 2017-02-14 | 57.43M shares 10-Q · filed 2017-02-14 | 57.34M shares derived: average of 3 quarters · filed 2017-09-28 | 57.24M shares derived: average of 4 quarters · filed 2017-09-28 | |
| 2015-09-30 | 57.27M shares 10-Q · filed 2016-11-14 | 57.21M shares derived: average of 2 quarters · filed 2017-09-28 | 57.12M shares derived: average of 3 quarters · filed 2017-09-28 | 56.98M shares derived: average of 4 quarters · filed 2017-09-28 | |
| 2015-06-30 | 57.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | 57.04M shares derived: average of 2 quarters · filed 2017-09-28 | 56.88M shares derived: average of 3 quarters · filed 2017-09-28 | 56.55M shares 10-K · filed 2017-09-28 | |
| 2015-03-31 | 56.94M shares 10-Q · filed 2016-05-10 | 56.75M shares derived: average of 2 quarters · filed 2016-05-10 | 56.36M shares 10-Q · filed 2016-05-10 | 55.76M shares derived: average of 4 quarters · filed 2016-09-16 | |
| 2014-12-31 | 56.56M shares 10-Q · filed 2016-02-09 | 56.07M shares 10-Q · filed 2016-02-09 | 55.37M shares derived: average of 3 quarters · filed 2016-09-16 | 54.86M shares derived: average of 4 quarters · filed 2016-09-16 | |
| 2014-09-30 | 55.58M shares 10-Q · filed 2015-11-09 | 54.78M shares derived: average of 2 quarters · filed 2016-09-16 | 54.29M shares derived: average of 3 quarters · filed 2016-09-16 | 53.23M shares derived: average of 4 quarters · filed 2016-09-16 | |
| 2014-06-30 | 53.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | 53.65M shares derived: average of 2 quarters · filed 2016-09-16 | 52.44M shares derived: average of 3 quarters · filed 2016-09-16 | 51.23M shares 10-K · filed 2016-09-16 | |
| 2014-03-31 | 53.32M shares 10-Q · filed 2015-05-15 | 51.68M shares derived: average of 2 quarters · filed 2015-05-15 | 50.31M shares 10-Q · filed 2015-05-15 | ||
| 2013-12-31 | 50.03M shares 10-Q · filed 2015-02-25 | 48.85M shares 10-Q · filed 2015-02-25 | |||
| 2013-06-30 | 45.89M shares 10-K · filed 2015-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |